Abstract
The article entitled, “MicroRNA-125b can Target p38MAPK to Resolve Intermittent Hypoxia-Induced Dementia in Murine Models” submitted in Current Neurovascular Research (CNR) by Dr. Xu Chen has been withdrawn from the journal in accordance with BSP Editorial Policies.
Current Neurovascular Research
Title:WITHDRAWN: MicroRNA-125b can Target p38MAPK to Resolve Intermittent Hypoxia- Induced Dementia in Murine Models
Volume: 16
Author(s): Haiyan Ren, Weibin Qiu, Chen Peng, Ying Ding, Benju Zhu, Qiang Li and Xu Chen*
Affiliation:
- Department of Neurology, Shanghai Eighth People’s Hospital, Shanghai,China
Abstract: The article entitled, “MicroRNA-125b can Target p38MAPK to Resolve Intermittent Hypoxia-Induced Dementia in Murine Models” submitted in Current Neurovascular Research (CNR) by Dr. Xu Chen has been withdrawn from the journal in accordance with BSP Editorial Policies.
Export Options
About this article
Cite this article as:
Ren Haiyan , Qiu Weibin, Peng Chen , Ding Ying, Zhu Benju , Li Qiang and Chen Xu *, WITHDRAWN: MicroRNA-125b can Target p38MAPK to Resolve Intermittent Hypoxia- Induced Dementia in Murine Models, Current Neurovascular Research 2019; 16 () . https://dx.doi.org/10.2174/1567202616666190211155309
DOI https://dx.doi.org/10.2174/1567202616666190211155309 |
Print ISSN 1567-2026 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5739 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Many Roles of Chemokine Receptors in Neurodegenerative Disorders: Emerging New Therapeutical Strategies
Current Medicinal Chemistry Blood-based Amyloid and Tau Biomarker Tests For Alzheimer’s Disease
Neuroscience and Biomedical Engineering (Discontinued) Palmitoylethanolamide Regulates Production of Pro-Angiogenic Mediators in a Model of β Amyloid-Induced Astrogliosis <i>In Vitro</i>
CNS & Neurological Disorders - Drug Targets Ignored Avenues in Alpha-Synuclein Associated Proteopathy
CNS & Neurological Disorders - Drug Targets Patent Selections
Recent Patents on Cardiovascular Drug Discovery Effects of Nicotine on the Cardiovascular System
Vascular Disease Prevention (Discontinued) Pharmacological Inhibition of Platelet Reactivity. Clinical and Pharmacodynamic Effects
Current Vascular Pharmacology Genetic Studies of Type 2 Diabetes in South Asians: A Systematic Overview
Current Diabetes Reviews Treating Hypertension in the Elderly: Common Problems and Solutions
Current Hypertension Reviews Differential Regulation of microRNAs in Patients with Ischemic Stroke
Current Neurovascular Research Modelling Decline in Cognition to Decline in Function in Alzheimer’s Disease
Current Alzheimer Research Biomedical Applications of Gold Nanoparticles
Current Topics in Medicinal Chemistry Insight into the Role of Photoreception and Light Intervention for Sleep and Neuropsychiatric Behaviour in the Elderly
Current Alzheimer Research Brain Information Sharing During Visual Short-Term Memory Binding Yields a Memory Biomarker for Familial Alzheimer's Disease
Current Alzheimer Research Dietary Patterns and Cognitive Decline: key features for prevention
Current Pharmaceutical Design Therapy of XDR TB with Thioridazine a Drug Beyond Patent Protection but Eligible for Patent “As New Use”
Recent Patents on Anti-Infective Drug Discovery Targeting Functional Biomarkers in Schizophrenia with Neuroimaging
Current Pharmaceutical Design Diabetes Mellitus and Vascular Endothelial Dysfunction: Current Perspectives
Current Vascular Pharmacology Pro-inflammatory Cytokines Modulate Glial Apolipoprotein E Secretion
Current Alzheimer Research Ras Family Small GTPase-Mediated Neuroprotective Signaling in Stroke
Central Nervous System Agents in Medicinal Chemistry